 | | | | Students caught vaping in school can expect a lot more than a warning or detention in one North Texas district starting this fall. They will be forced to attend a special, isolated disciplinary school for a month. | | | | | | Lexicon Pharmaceuticals Inc said on Tuesday France's Sanofi SA will pay the drugmaker $260 million for the termination of their partnership to develop diabetes drug Zynquista. | | | | | | U.S. health investigators are casting a wide net to understand what is sickening hundreds of vapers across the country and still have not ruled out any product on the market, even as vaping industry officials highlight the potential role of illegal cannabis products. | | | | | | (Reuters Health) - Women in pediatrics still earn less than men even with similar levels of experience and even after accounting for the disproportionate amount of time they devote to unpaid work at home, two new studies suggest. | | | | | | A Kansas resident was the sixth person to die in the United States of a mysterious respiratory illness related to vaping, state officials said on Tuesday, as public health officials scrambled to understand a nationwide health problem. | | | | | | U.S. public health officials are investigating more than 450 cases of severe lung illnesses and have confirmed at least five deaths related to electronic cigarette products including the devices and liquids used inside them. | | | | | | (Reuters Health) - The likelihood that U.S. patients with renal failure will get a kidney transplant is lower for those who get dialysis at for-profit dialysis centers, a new study shows. | | | | | | (Reuters Health) - Teens with chronic illnesses would like to have a say in decisions such as switching to a new medicine, but they often feel left out of the conversation, a small study suggests. | | | | | | (Reuters Health) - About one in five kids are prescribed opioids after common pediatric surgeries, but a new study suggests they may do just as well with alternative pain relievers like acetaminophen or ibuprofen. | | | | | | The U.S. Food and Drug Administration has approved Xeris Pharmaceuticals Inc's glucagon therapy that aims to treat severely low sugar levels in diabetes patients, the drugmaker said on Tuesday. | | | | | | The top U.S. consumer and trade regulator said on Tuesday it had warned three companies selling products infused with cannabidiol that it was illegal to advertise that such products could fight disease without providing credible scientific evidence. | | | | | |
